Molecular Partners
MOLN
7 hedge funds and large institutions have $3.91M invested in Molecular Partners in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0.08% more ownership
Funds ownership: 2.56% → 2.64% (+0.08%)
0% more funds holding
Funds holding: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
32% less capital invested
Capital invested by funds: $5.73M → $3.91M (-$1.82M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$342K |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$91 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$102K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$70.9K |
MOLN Hedge Fund Activity: Q3 2023 in Review
7 of the 6,309 institutional investors tracked by Wall St. Rank reported a position in Molecular Partners (MOLN) for Q3 2023, worth a combined $3.91M — down 32% from $5.73M a quarter earlier.
Fund positioning in MOLN was balanced in Q3 2023: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Tang Capital Management, adding an estimated $342K. The largest seller was Jane Street, exiting entirely with an estimated $102K sold.
- 7 institutional investors held Molecular Partners (MOLN) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $3.91M of Molecular Partners stock for Q3 2023, down 32% quarter-over-quarter.
- 1 fund opened new Molecular Partners positions in Q3 2023 and 1 closed out, a net change of 0 holders.
- The largest Molecular Partners buyer in Q3 2023 was Tang Capital Management, an estimated $342K added.
- The largest Molecular Partners seller in Q3 2023 was Jane Street, an estimated $102K sold.
Based on aggregated 13F filings for Q3 2023.